ArticleJournal of the Chinese Medical Association : JCMA2022

Comparing paclitaxel-platinum with ifosfamide-platinum as the front-line chemotherapy for patients with advanced-stage uterine carcinosarcoma.

Ming-Hsuan Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.